Conference Coverage
Conference Coverage
Swapping bortezomib for vincristine improves PFS in mantle cell lymphoma
Key clinical point: Substituting bortezomib for vincristine may bring clinical benefit to patients with newly diagnosed mantle cell lymphoma who...
Conference Coverage
VIDEO: Ibrutinib boosts survival of relapsed/refractory CLL
Conference Coverage
RIT can improve transplant outcomes in NHL, CLL
Ryan Cassaday, MD, of the University of Washington in Seattle, noted that RIT-augmented NMAT can produce long-term remissions in patients with...
Conference Coverage
ONO-4059 makes waves in heavily pretreated CLL
Major finding: The response rate was 89% overall and 71% for patients with 17p deletion. Data source: A prospective, phase I dose-escalation study...
Conference Coverage
'Highest response rate ever reported' in relapsed mantle cell lymphoma
Major Finding: In an efficacy cohort of 110 patients with relapsed or refractory mantle cell lymphoma, 22% had a complete response and 46% a...
Conference Coverage
CNS Events Not Immediately Fatal in Mantle Cell Lymphomas
Major Finding: Crude prevalences of CNS involvement at diagnosis and overall were 0.9% and 4.1%, respectively, with a median time to an event of...
Conference Coverage
Pregnant Women With Lymphoma Can Have Good Outcomes
Major Finding: Among women with lymphomas diagnosed during pregnancy, the 3-year progression-free survival rates were 76% in women who underwent...